Nausea rates in the STEP trials were 44%, substantially higher than Retatrutides 28%
Intravenous Injections: Use appropriate IV push or infusion codes
Although rare, more moderate side effects are vomiting, diarrhea, trouble breathing, facial swelling, severe lethargy, or collapsein these cases stop the peptide immediately and seek veterinary support
If youre experiencing any of these symptoms, our patient-centered peptide therapy may be the solution to revitalize your body and mind
Go to the BPC-157 page for more information on research applications
Food and Drug Administration has recently reviewed several peptides and recommended that 4 BPC-157, KPV, TB-500 and MOTS-C be considered for compounding, which allows specially licensed pharmacies to produce customized medications